These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20337506)

  • 1. Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence.
    Knapp CM; Sarid-Segal O; Richardson MA; Colaneri LS; Afshar M; Devine E; Streeter CC; Piechniczek-Buczek J; Ciraulo DA
    Am J Drug Alcohol Abuse; 2010 Mar; 36(2):102-5. PubMed ID: 20337506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.
    Knapp CM; Ciraulo DA; Sarid-Segal O; Richardson MA; Devine E; Streeter CC; Oscar-Berman M; Surprise C; Colaneri L; Putnam M; Waters M; Richambault C
    J Clin Psychopharmacol; 2015 Feb; 35(1):34-42. PubMed ID: 25427171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial.
    Guerrini R; Rosati A; Bradshaw K; Giorgi L
    Epilepsia; 2014 Apr; 55(4):568-78. PubMed ID: 24621319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of an oral zonisamide loading dose.
    Jongeling AC; Richins RJ; Bazil CW
    Seizure; 2015 Nov; 32():69-71. PubMed ID: 26552566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.
    McElroy SL; Suppes T; Keck PE; Black D; Frye MA; Altshuler LL; Nolen WA; Kupka RW; Leverich GS; Walden J; Grunze H; Post RM
    J Clin Psychiatry; 2005 May; 66(5):617-24. PubMed ID: 15889949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients.
    Anand A; Bukhari L; Jennings SA; Lee C; Kamat M; Shekhar A; Nurnberger JI; Lightfoot J
    J Clin Psychiatry; 2005 Feb; 66(2):195-8. PubMed ID: 15705004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence of zonisamide orally dispersible tablet and immediate-release capsule formulations: results from two open-label, randomized-sequence, single-dose, two-period, two-treatment crossover studies in healthy male volunteers.
    Maanen Rv; Bentley D
    Clin Ther; 2009 Jun; 31(6):1244-55. PubMed ID: 19695391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled trial of zonisamide for the treatment of alcohol dependence.
    Arias AJ; Feinn R; Oncken C; Covault J; Kranzler HR
    J Clin Psychopharmacol; 2010 Jun; 30(3):318-22. PubMed ID: 20473070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.
    McElroy SL; Kotwal R; Hudson JI; Nelson EB; Keck PE
    J Clin Psychiatry; 2004 Jan; 65(1):50-6. PubMed ID: 14744168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital.
    Hasegawa H
    Curr Med Res Opin; 2004 May; 20(5):577-80. PubMed ID: 15140322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide therapy for refractory idiopathic epilepsy in dogs.
    Dewey CW; Guiliano R; Boothe DM; Berg JM; Kortz GD; Joseph RJ; Budsberg SC
    J Am Anim Hosp Assoc; 2004; 40(4):285-91. PubMed ID: 15238558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures.
    Faught E; Ayala R; Montouris GG; Leppik IE;
    Neurology; 2001 Nov; 57(10):1774-9. PubMed ID: 11723262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.
    Kanba S; Yagi G; Kamijima K; Suzuki T; Tajima O; Otaki J; Arata E; Koshikawa H; Nibuya M; Kinoshita N
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):707-15. PubMed ID: 7938561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Zonisamide as add-on treatment for focal epilepsies. An outcome analysis of 74 patients].
    Wellmer S; Wellmer J; Bauer J
    Nervenarzt; 2008 Dec; 79(12):1416, 1418-23. PubMed ID: 18633587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Brodie MJ; Patten A; Segieth J; Giorgi L
    Lancet Neurol; 2012 Jul; 11(7):579-88. PubMed ID: 22683226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide monotherapy for epilepsy in children and young adults.
    Wilfong AA
    Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide for migraine prophylaxis in refractory patients.
    Ashkenazi A; Benlifer A; Korenblit J; Silberstein SD
    Cephalalgia; 2006 Oct; 26(10):1199-202. PubMed ID: 16961786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.